Literature DB >> 10811112

WRN or telomerase constructs reverse 4-nitroquinoline 1-oxide sensitivity in transformed Werner syndrome fibroblasts.

F M Hisama1, Y H Chen, M S Meyn, J Oshima, S M Weissman.   

Abstract

WRN encodes a RecQ helicase, which is mutated in Werner syndrome. Werner syndrome is a genetic condition of young adults characterized by premature aging, limited replicative capacity of cells in vitro, and increased cancer risk. Telomerase is a reverse transcriptase that extends the G-rich strand of telomeric DNA. Primary cells in vitro typically lack telomerase activity and undergo senescence, whereas telomerase is reactivated in many, but not all, tumors. The roles of the two genes are not known to be related. Here we report the development of an effective colony-forming assay in which a SV40-transformed Werner fibroblast cell line is 6-18-fold more sensitive to 4-nitroquinoline 1-oxide than SV40-transformed normal cell lines. The sensitivity can be partially reversed by transfecting a normal WRN gene but not a mutated WRN gene into the cells. Curiously, the sensitivity can be reversed equally well by transfecting a telomerase gene (TERT) into the cells. These data indicate the possibility of an interdependent function of these two genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811112

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Werner protein recruits DNA polymerase delta to the nucleolus.

Authors:  A M Szekely; Y H Chen; C Zhang; J Oshima; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Werner syndrome protein interacts with human flap endonuclease 1 and stimulates its cleavage activity.

Authors:  R M Brosh; C von Kobbe; J A Sommers; P Karmakar; P L Opresko; J Piotrowski; I Dianova; G L Dianov; V A Bohr
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

3.  The Werner Syndrome Helicase Coordinates Sequential Strand Displacement and FEN1-Mediated Flap Cleavage during Polymerase δ Elongation.

Authors:  Baomin Li; Sita Reddy; Lucio Comai
Journal:  Mol Cell Biol       Date:  2017-01-19       Impact factor: 4.272

4.  Werner protein protects nonproliferating cells from oxidative DNA damage.

Authors:  Anna M Szekely; Franziska Bleichert; Astrid Nümann; Stephen Van Komen; Elisabeth Manasanch; Abdelhakim Ben Nasr; Allon Canaan; Sherman M Weissman
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 5.  Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions.

Authors:  Junko Oshima; Julia M Sidorova; Raymond J Monnat
Journal:  Ageing Res Rev       Date:  2016-03-15       Impact factor: 10.895

6.  WRN helicase promotes repair of DNA double-strand breaks caused by aberrant mismatch repair of chromium-DNA adducts.

Authors:  Alma Zecevic; Haley Menard; Volkan Gurel; Elizabeth Hagan; Rosamaria DeCaro; Anatoly Zhitkovich
Journal:  Cell Cycle       Date:  2009-09-02       Impact factor: 4.534

7.  Sensitivity of RECQL4-deficient fibroblasts from Rothmund-Thomson syndrome patients to genotoxic agents.

Authors:  Weidong Jin; Hao Liu; Yiqun Zhang; Subhendu K Otta; Sharon E Plon; Lisa L Wang
Journal:  Hum Genet       Date:  2008-05-27       Impact factor: 4.132

8.  Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes.

Authors:  Xiaobing Du; Johnny Shen; Nishan Kugan; Emma E Furth; David B Lombard; Catherine Cheung; Sally Pak; Guangbin Luo; Robert J Pignolo; Ronald A DePinho; Leonard Guarente; F Brad Johnson
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

9.  Differential in vitro cytotoxicity does not explain increased host toxicities from chemotherapy in Down syndrome acute lymphoblastic leukemia.

Authors:  Mariela Valle; Sharon E Plon; Karen R Rabin
Journal:  Leuk Res       Date:  2008-08-20       Impact factor: 3.156

Review 10.  Telomerase deficiency and cancer susceptibility syndromes.

Authors:  Rosario Perona; Rosario Machado-Pinilla; Cristina Manguan; Jaime Carrillo
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.